Lidocaine is the monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline. Among its listed roles, it functions as a local anaesthetic, an anti-arrhythmia drug, an environmental contaminant, a xenobiotic and a drug allergen. It is a monocarboxylic acid amide, a tertiary amino compound and a member of benzenes. Functionally, it is related to glycinamide. It is grouped under the following drug class(es): Amide local anesthetics. Its therapeutic use is listed as analgesics, anesthetics, antiarrhythmics, cardiovascular, dermatologicals and sexual dysfunction agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Xylocaine and Lidoderm. Its PubChem CID is 3676.
Lidocaine
| CAS No | 137-58-6 |
|---|---|
| Molecular Formula | C14H22N2O |
| Molecular Weight | 234.34 g/mol |
| Synonyms | 2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Lidocaine is the monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline. Among its listed roles, it functions as a local anaesthetic, an anti-arrhythmia drug, an environmental contaminant, a xenobiotic and a drug allergen.
The listed CAS number is 137-58-6.
The listed molecular formula is C14H22N2O.
The listed molecular weight is 234.34 g/mol.
2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide.
The source lists Xylocaine and Lidoderm.